# Vanqua Bio funding: rounds and investors

> Vanqua Bio has raised $130M across 2 rounds since 2021. Investors include Omega Funds, OrbiMed and Eli Lilly. Every round with its source.

Source: https://millionrounds.com/company/vanqua-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Venture startup](https://millionrounds.com/companies)

# Who invested in *Vanqua Bio*

2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$130M** raised across 2 rounds since 2021, from 2 sources

**$85M** Series B **$45M** Venture

- **Latest round:** Venture, $45M Jul 2024
- **Biggest round:** $85M Series B · Sept 2021
- **Investors:** 9 (1 led)

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2022 2023 2024

**$85M** Series B

**$45M** Venture

- **First round:** Series B, $85M
- **Biggest round:** $85M
- **Between rounds:** 2.8 years

## The rounds

- **Jul 2024** Venture **$45M** *4 returning* [OrbiMed](https://millionrounds.com/fund/orbimed) [Eli Lilly](https://millionrounds.com/fund/eli-lilly) [Casdin Capital](https://millionrounds.com/fund/casdin-capital) [Omega Funds](https://millionrounds.com/fund/omega-funds) Source recorded SEC filing: $45M sold, first sale Feb 2024
- **Sept 2021** Series B **$85M** *9 new* [Omega Funds](https://millionrounds.com/fund/omega-funds) Lead [OrbiMed](https://millionrounds.com/fund/orbimed) [Eli Lilly](https://millionrounds.com/fund/eli-lilly) [Casdin Capital](https://millionrounds.com/fund/casdin-capital) [Osage University Partners](https://millionrounds.com/fund/osage-university-partners) [Logos Capital](https://millionrounds.com/fund/logos-capital) [Surveyor Capital](https://millionrounds.com/fund/surveyor-capital) [Pontifax](https://millionrounds.com/fund/pontifax) [Avoro Ventures](https://millionrounds.com/fund/avoro-ventures) Reported by Firms' own news pages SEC filing: $85M sold, first sale Aug 2021

## Founders and team

From Vanqua Bio's own website: 4 on the team.

- **Tim Daly** Vice President, Finance and Corporate Controller
- **Hunter Smith** CFO – Rhythm Pharma
- **Jack Beyer** Chief Business Officer
- **Mackenzie Hagey** VP Development

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series B** 2021 **Venture** 2024 [Omega Funds](https://millionrounds.com/fund/omega-funds) L [OrbiMed](https://millionrounds.com/fund/orbimed) [Eli Lilly](https://millionrounds.com/fund/eli-lilly) [Casdin Capital](https://millionrounds.com/fund/casdin-capital) [Osage University Partners](https://millionrounds.com/fund/osage-university-partners) [Logos Capital](https://millionrounds.com/fund/logos-capital) [Surveyor Capital](https://millionrounds.com/fund/surveyor-capital) [Pontifax](https://millionrounds.com/fund/pontifax) [Avoro Ventures](https://millionrounds.com/fund/avoro-ventures)

## Everyone who backed them

[Omega Funds](https://millionrounds.com/fund/omega-funds) VC firm **2** rounds, led 1

[OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **2** rounds

[Eli Lilly](https://millionrounds.com/fund/eli-lilly) Corporate VC **2** rounds

[Casdin Capital](https://millionrounds.com/fund/casdin-capital) VC firm **2** rounds

[Osage University Partners](https://millionrounds.com/fund/osage-university-partners) VC firm **1** round

[Logos Capital](https://millionrounds.com/fund/logos-capital) VC firm **1** round

[Surveyor Capital](https://millionrounds.com/fund/surveyor-capital) VC firm **1** round

[Pontifax](https://millionrounds.com/fund/pontifax) Growth equity **1** round

[Avoro Ventures](https://millionrounds.com/fund/avoro-ventures) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=vanqua-bio).

## Also claim to have backed them

This firm lists Vanqua Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Avoro Capital Advi...](https://millionrounds.com/fund/avoro-capital-advi) Private equity Per its own site

## Quick answers about Vanqua Bio

### Who invested in Vanqua Bio?

Vanqua Bio's investors include Omega Funds, OrbiMed, Eli Lilly, Casdin Capital and Osage University Partners, and 4 more on record.

### How much has Vanqua Bio raised?

Vanqua Bio has raised $130M across 2 rounds since 2021.

### When did Vanqua Bio last raise?

Vanqua Bio's most recent round was a Venture of $45M in Jul 2024.

### What was Vanqua Bio's biggest round?

Vanqua Bio's largest round on record is $85M (Series B), in Sept 2021, led by Omega Funds.

### Who backed Vanqua Bio first?

Vanqua Bio's first round on record, in Sept 2021, was backed by Omega Funds, OrbiMed and Eli Lilly and 6 others.

### What stage is Vanqua Bio at?

Vanqua Bio's latest named round is a Venture, in Jul 2024.

### Where is Vanqua Bio based?

Vanqua Bio is based in the United States.

### Who led Vanqua Bio's rounds?

Omega Funds led the Series B in 2021.

## Companies like Vanqua Bio

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
